You can buy or sell InspireMD and other stocks, options, ETFs, and crypto commission-free!
InspireMD, Inc., also called InspireMD, is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. Read More The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
Tel Aviv, Tel Aviv
52 Week High
52 Week Low
Seeking AlphaFeb 19
InspireMD -3% on Q4 results
InspireMD (NSPR) Q4 results: Revenues: $0.82M (-1.2%). Net Loss: ($2.2M) (+60.0%); Loss Per Share: ($0.05) (+99.3%); Quick Assets: $9.4M (+154.1%). The Company is on-track to submit U.S. IDE in mid-2019. Shares are down 3% premarket. Previously: InspireMD reports Q4 results (Feb. 19)...
Expected May 6, After Hours